Volitionrx (VNRX) Income towards Parent Company (2012 - 2025)
Volitionrx (VNRX) posted Income towards Parent Company of $260595.0 for Q4 2025, up 929.05% on a QoQ basis from -$31433.0 in Q3 2025, and down 49.54% year-over-year from $516444.0 in Q4 2024.
Volitionrx (VNRX) Income towards Parent Company (2012 - 2025) Analysis & Trends
Volitionrx's Income towards Parent Company history runs 10 years deep, the most recent figure standing at $260595.0 for Q4 2025.
- Quarterly Income towards Parent Company fell 49.54% year-over-year to $260595.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.7 million (up 31.64% YoY) and the FY2025 annual result came in at $146302.0, down 49.58% from the prior year.
- Income towards Parent Company was $260595.0 for Q4 2025 at Volitionrx, up from -$31433.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $516444.0 in Q4 2024 and bottomed at -$10.1 million in Q2 2023.
- A 5-year average of -$4.1 million and a median of -$3.0 million in 2024 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2021 — Income towards Parent Company tumbled 88751.34% — and 2022, when it surged 791.1%.
- Volitionrx's Income towards Parent Company stood at -$8.0 million in 2021, then climbed by 9.87% to -$7.2 million in 2022, then slipped by 21.38% to -$8.8 million in 2023, then jumped by 105.88% to $516444.0 in 2024, then tumbled by 49.54% to $260595.0 in 2025.
- Business Quant data shows VNRX's Income towards Parent Company at $260595.0 in Q4 2025, -$31433.0 in Q3 2025, and $29992.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Volitionrx | 89,525.10 | -1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 260,595.00 |
| Sep 30, 2025 | -31,433.00 |
| Jun 30, 2025 | 29,992.00 |
| Mar 31, 2025 | -5.94 Mn |
| Dec 31, 2024 | 516,444.00 |
| Sep 30, 2024 | -47,049.00 |
| Jun 30, 2024 | 74,629.00 |
| Mar 31, 2024 | -8.85 Mn |
| Dec 31, 2023 | -8.79 Mn |
| Sep 30, 2023 | -9.20 Mn |
| Jun 30, 2023 | -10.10 Mn |
| Mar 31, 2023 | -9.63 Mn |
| Dec 31, 2022 | -7.24 Mn |
| Sep 30, 2022 | -7.74 Mn |
| Jun 30, 2022 | 82,302.00 |
| Mar 31, 2022 | 83,977.00 |
| Dec 31, 2021 | -8.04 Mn |
| Sep 30, 2021 | -7.14 Mn |
| Jun 30, 2021 | 47,539.00 |
| Mar 31, 2021 | 9,424.00 |